Albireo Pharma (ALBO) Reports FY16 Loss of $13.16

Albireo Pharma (NASDAQ: ALBO) reported FY16 EPS of ($13.16), versus ($25.49) reported last year. Revenue for the year came in at $11.4 million, versus $5.1 million reported last year.

For earnings history and earnings-related data on Albireo Pharma (ALBO) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• L3Harris CEO steps down amid conduct review, shares drop
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c